Spots Global Cancer Trial Database for Clonal Hematopoiesis in Ovarian Cancer Survivors and Risk of Secondary Blood Cancers
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clonal Hematopoiesis in Ovarian Cancer Survivors and Risk of Secondary Blood Cancers
Official Title: Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Ovarian Cancers (CHANCES)
Study ID: NCT06295965
Interventions
Study Description
Brief Summary: This study is being done to investigate clonal hematopoiesis and therapy-emergent myeloid neoplasms in patients with ovarian cancers. Researchers want to identify risk factors for developing these blood cancers as well as if there is/are a genetic/environmental component(s) to developing blood cancer.
Detailed Description: OUTLINE: This is an observational study. Patients undergo blood sample collection and complete surveys on study. Patients' medical records are also reviewed.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States
Contact Details
Name: Elizabeth Swisher
Affiliation: Fred Hutch/University of Washington Cancer Consortium
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
